OncoMed Pharmaceuticals Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- Stifel sees AI supply constraints ahead of Q3 tech earnings
- Schneider Electric to buy US software firm PTC in $22.6 billion deal
OncoMed Pharma (OMED) Misses Q3 EPS by 4c
November 5, 2015 9:20 AM ESTOncoMed Pharma (NASDAQ: OMED) reported Q3 EPS of ($0.81), $0.04 worse than the analyst estimate of ($0.77).
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
... More


